2/IL2R system, could be a possible candidate for the prolifer-
Introduction
Normal NK cells can be activated by several cytokines. Indeed, when NK cells are exposed to IL-2, IL-7, IL-12 or interNatural killer (NK) cells represent a small proportion of the ferons they become activated NK cells, 28, 29 which lyse a broad peripheral blood lymphocytes which, frequently, display azyrspectrum of both autologous malignant cells or cells from ophilic granules and, thus, also named large granular lymphoestablished cell lines. It has been demonstrated that IL-2 acticytes (LGL). However, detailed phenotypic and genotypic vates NK cells through membrane CD122 chains 16, 19 inducing studies of LGL clearly demonstrated that there are two distinct the transcription and the membrane expression of the CD25 cell populations: LGL bearing the phenotype CD3 − , CD16 + , chain gene. [17] [18] [19] Therefore, CD122 chains and high affinity IL-CD56 + without rearrangement of TCR genes (NK cell origin), 2R regulate, at least partly, the proliferation of NK cells. 19 and those which are CD3 + , CD16 + , CD56 + with rearrangeUntil recently, very few neoplastic NK cell lines have been ment of the TCR genes (T cell origin).
1-5 Clonal expansions of established. [30] [31] [32] [33] [34] The YT leukemic NK cell line, displaying the these cells may account for some cases of acute leukemias CD16 + , CD56 + cell phenotype expresses high affinity IL-2R with poor prognosis.
6 CD3 + leukemias exhibit specific clinical and proliferates without the addition of exogenous IL-2. 30 On manifestations (rheumatoid arthritis, recurrent bacterial infecthe other hand, the NK-92 cell line, expresses both CD25 and tions, chronic neutropenia and, occasionally, pure red blood CD122 chains in about 50% of cells but requires exogenous cell aplasia) whereas CD3 − leukemias are manifested by mass-IL-2 for cell proliferation. 31 However, stimulation of LGL from ive hepato-splenomegaly, lymphadenopathy, skin involveseven patients with phenotypically homogeneous LGL with IL- inase and prednisone as well as CNS prophylaxis with intrathecal administration of methotrexate and prednisone was and proliferate under their own production of IL-2, indicating an autocrine involvement of the IL-2/IL-2R system in their initiated. A complete response of short duration (6 months) was obtained and the patient died 19 months later after a bone growth. marrow relapse.
Patients and methods

Cells and cell culture Patients
Peripheral blood mononuclear cells (MNC) were obtained at A 45-year-old man was admitted to our institution with a 14-presentation before the initiation of any chemotherapy. MNC day history of cervical, sub-clavicular and mediastinal adencells were isolated by Ficoll-Paque (Pharmacia Fine Chemiopathy, hemorrhagic skin lesions, low back pain, asthenia, cals, Uppsala, Sweden) density (d = 1077 g/cm 3 ) gradient cencough, dyspnea, anemia and thrombocytopenia. A hyperleutrifugation and cells (10 6 /ml) were resuspended in RPMI-1640 kocytosis with a diffuse (98%) presence of lymphoid cells (Gibco, Gaithersburg, MD, USA) supplemented with heatcharacterized as lymphoblasts was observed (Figure 1a ). Cytoinactivated fetal calf serum (Eurobio, Les Oulis, France) (10% v/v) and 2 mM L-glutamine (Eurobio) (complete growth medium). The cells (10 6 /ml) were subsequently cultured in the absence of any added growth factor or mitogen at 37°C in 5% CO 2 in air. Every 3 days the cultures were centrifuged, the viable cells were counted using Trypan blue dye exclusion 
tips of the tubes containing the cell pellet were cut off and the cell-bound and cell-free radioactivity were counted in a (CD15), IOM2 (CD14), IOM33 (CD33), Immu-133 (CD34), IOT56 (CD56), IOT10 (CD57) and IOT 14 (CD25 or IL-2R␣) gamma counter. Non-specific binding was determined in the presence of a 500-fold excess of unlabelled rIL-2 (Amgen, which were obtained from Immunotech (Lumigny, France). Moreover, the CD25 (IL-2R␣) was tested using the IOT 14␣
Thousand Oaks, CA, USA). The number of binding sites per cell and the dissociation constant (K d ) were evaluated by Scat-(Immunotech) and the 7G7/B6 (kindly provided to us by Dr B Azzarone, INSERM U268, Paris, France) moAbs. The chard analysis. CD122 (IL-2R␤) was analyzed using the TU-27, mik␤1 and mik␤3 moAbs (kindly provided to us by Pr Sugamura, University of Osaka, Japan). Detection of IL-2 bound on the cells
Preparation of conditioned media (CM)
was performed using the DMS-1 moAb (Genzyme, Cinisello, Balsamo, Italy). FITC-goat anti-mouse F(ab) 2 immunoglobulins Both fresh leukemic (10 6 /ml) and continuously growing (10 6 /ml) cells were washed twice in complete growth medium were added as second reagent. Analysis was performed in a fluorescence-activated cell sorter (Coulter, Miami, FL, USA).
and resuspended in growth medium for 48 h as described above. At the end of the culture period, cultures were centrifuged and supernatants (CM) were Millipore (0.22 )-filtered and stored at −80°C until use. In some experiments, cells were Cytogenetic analysis washed with phosphate-buffered saline (PBS; Eurobio) supplemented with glycine (pH 3.5) and the washing buffer was To obtain metaphases, cells were pooled in 0.2 ml PBS. Colcemid was added at a final dilution of 0.01 g/ml and cells recovered and tested for IL-2 as described below. In other experiments, CM were 10-fold concentrated using an Amicon were incubated at 37°C for 60-90 min. Subsequently, cells were exposed to a hypotonic solution with 0.075 mol/l KCl apparatus, as has been previously described. 38 and fixed in methanol:acetic acid (3:1, v/v). Air-dried slide preparations were made, stained with Giemsa, and examined microscopically for well-spread metaphases. The chromoAnalysis of J H and T cell receptor genes configuration somal structure was studied using the G-trypsin Giemsa (GTG) banding technique. 36 Slide preparations were submerged in a High molecular weight DNA extracted from NOI-90 cells was digested with BamHI and EcoRI restriction enzymes, size fractrypsin solution (0.1% v/v) (Sigma Chemical, St Louis, MO, USA) at 22°C for 40-120 s and stained with Giemsa. The tionated on a 0.9% agarose gel by electrophoresis and transferred to nitrocellulose filters. DNA fragments were then International nomenclature was used. 37 hybridized to nick-translated 32 P probes and visualized by autoradiography. The human Ig gene probe was a 2.6 kb Sau3 fragment of the germ line J H region. The T cell receptor ␤-
51
Cr release assay chain probe was a 0.4-kb BglII C␤2 fragment which hybridizes with both C␤I and C␤2. The TCR␥ probe was a Cytotoxic activity was determined by a 4-h 51 Cr release assay. K-562, Raji and Daudi cells, used as target cells (10 6 ), were 0.9 kb BstXI-EcoRI fragment of the constant region of human TCR␥ cDNA.
39 suspended in 0.1 ml of the culture medium, labelled with 100 Ci of Na 2 Cr0 4 (Amersham, Life Science, Arlington Heights, IL, USA) for 2 h at 37°C, and then washed extensively before use. 51 Cr-labelled target cells, suspended in 50 l of Detection of IL-2 the culture medium, and effector cells, suspended in 100 l of the culture medium, were plated in round-bottomed 96-IL-2 activity in CM was determined using the IL-2-dependent CTLL-2 mouse cell line according to the method described by well microtiter plates (Costar, Cambridge, MA, USA) at various effector:target (E:T) ratios. The microtiter plate was centriMosman 40 as modified by Tada. 41 Briefly, 50 l of two-fold dilutions of the supernatant to be tested were added per well fuged at 50 g for 5 min to establish effector and target cell conjugation. After 4-h incubation at 37°C, the microtiter plate in 96 flat-bottomed microplates. Then, 6 × 10 3 CTLL-2 cells, resuspended in complete growth medium supplemented with was centrifuged at 400 g for 5 min. One hundred microliters were harvested and radioactivity determined in a gamma 10 −4 m 2-mercaptoethanol, were added to each microwell.
Microplates were incubated at 37°C in 5% CO 2 in air for 24 h strated that the peak of cell proliferation was at 48 h with an increase ranging from 38% to 60%. NOI-90 cells could be and viable proliferating cells were detected by adding 20 l/well of bromure 3-(4,5,dimethylthiazol)-2.5-diphenyltestored both at −80°C and in liquid nitrogen; cell recovery could be obtained even after a 3-year storage. Morphologitrazolium (MTT; Sigma, stock solution 5 mg/ml in PBS); 100 l of 10% SDS-HCl 0.01 m were added for an additional 4-6 h.
cally, the cells displayed a lymphoblastoid appearance ( Figure 1b ) and cytochemically they were proven to be myeloControls included two-fold dilutions of 50 U/ml rIL-2, complete growth medium and complete growth medium supperoxidase-and non-specific esterase negative but acid phosphatase positive (Table 1) . Genotypic analysis of the cells plemented with two-fold dilutions of rIL-2. Absorbance was monitored at 570 nm using a spectrophotometer. In addition, revealed that J H , TCR␤ and TCR␥ genes are in germ line (not shown), whereas karyotypic analysis, performed 2 years after the presence of IL-2 in culture supernatants or cell lysates was determined using an immunoenzymatic sandwich assay based the initial culture, revealed that all mitoses displayed a 47XY, +8, 17p-karyotype (Table 1) . Moreover, phenotypic characon two monoclonal antibodies recognizing distinct epitopes of the IL-2 molecule (Intertest; Genzyme), according to the terization of NOI-90 cells revealed that they did not express B-, and myeloid/monocyte-associated antigens. Moreover, manufacturer's instructions.
they did not express the CD5, CD7, CD10, CD13, CD14, CD16, and CD34 antigens (less than 2%). Conversely, cells expressed the CD3, CD56 and CD57 but not the CD2, CD4, Biochemical characterization of IL-2 CD1 and CD8 molecules (Table 1 ). In addition, 4% of the NOI-90 cells could be stained with the TU27 moAb (antiMedia conditioned by NOI-90 cells were Amicon-concentrated and were adsorbed by immuno-affinity on a Sepharose CD122) whereas no positivity could be detected on the initial blast cells. Furthermore, using the IOT14 moAb (anti-CD25), column coupled with 3 mg purified polyclonal anti-IL2 IgG (Endogen, Cambridge, MA, USA) equilibrated in PBS. The which could not neutralize IL-2-driven normal T cell proliferation, 2% and 0% of the NOI-90 and fresh leukemic cells non-retained fraction was adsorbed twice. The column was further washed with 10 volumes PBS, 0.35 m NaCl, pH 7.4 respectively, could be stained (Table 1) . and the retained proteins were eluted with PBS, 1 m glycine, pH 2. Table 2 shows that almost the same number of high affinity binding sites could be detected on fresh leukemic for 30 min at 37°C with various concentrations of moAbs against the CD25 (IOT14, IOT14␣, 7G7/B6) and CD122 cells, fresh cells cultured for 48 h in the absence of added growth factors and on NOI-90 cells continuously cultured (mik␤1, mik␤3 and TU-27) molecules (IL-2R␣ and IL-2R␤ chains, respectively) or neutralizing goat anti-human purified without growth factors for up to 18 months. In all experiments, the K d of IL2-binding sites ranged between 152 pM and antibodies against the recombinant human IL-2 (BDA 9, R & D Systems, Abingdon, UK) before being seeded. The anti-IL-2 antibodies could neutralize 1.75 ng/ml of IL-2 in CTLL-2 cells CEA, Saclay, France) and cell-associated radioactivity was counted by liquid scintillation. The dotted curve represents the described. Non-specific binding was evaluated in the presence of a non-specific staining controls. 500-fold excess of unlabelled rIL-2 and subtracted.
experiments (not shown). Several kinetic experiments demon-
an anti-IL-2 moAb; Figure 3 clearly demonstrates that 37% of NOI-90 cells could be specifically stained.
To define more precisely the nature of the IL-2 activity 187 pM which corresponds to high affinity IL-2R.
42 Figure 2 detected in the supernatant of NOI-90 cells, the 10-fold conrepresents a typical IL-2 binding experiment on established centrated material was adsorbed on polyclonal purified rabbit NOI-90 cells.
anti-IL2 IgG fixed to Sepharose. The retained fractions contained 300 U/ml of Il-2 whereas the non-retained fractions contained only 22 U/ml. SDS-PAGE of retained and non-IL-2 production by NOI-90 cells membrane. However, cell immunostaining with either IOT14 The 10-fold concentrated supernatant contained 50 U/ml of or TU-27 moAbs could not reveal the presence of CD25 and IL-2 activity, as detected by the immunoenzymatic assay CD122 chains respectively, although 125 I-rIL2 binding experi- (Table 4) . To determine further whether NOI-90 cells produce ments revealed the presence of high affinity IL-2R. In order to IL-2, cells were washed with acid PBS (pH 3.5), in order to evaluate more accurately the expression of IL-2R chains on remove IL-2 already bound on the membrane; moreover, son-NOI-90 cells, additional experiments were performed using icated cell lysates were tested for IL-2 activity. Table 3 indimoAbs recognizing different epitopes of each chain. Both the cates that both acid washing medium and cell lysates con-IOT14, which is a non-neutralizing antibody and the IOT14␣, tained substantial amounts of IL-2. Since detection of IL-2 in which is a neutralizing Ab, could not reveal the presence of acid washing medium suggests that the molecule is adsorbed CD25 chains on the cells. Conversely, the moAb 7G7/B6 on the cell membrane, NOI-90 cells were further stained with which binds on a different site than IL-2 could positively stain 25% of the cells (Figure 4 ). In addition, both the TU-27 and NOI-90 cells (10 6 /ml) were incubated for 48 h in 5% CO 2 in air in order to prepare conditioned media (CM). In addition, NOI-90 cells (10 6 /ml) were washed with PBS supplemented with glycine (pH 3.5), centrifuged and the cell pellet was lysed by sonication. Both the acid washing medium and the cell lysates were tested for IL-2 the mik␤1 moAbs could not reveal positive cells whereas 13% present study is different from the cases of CD3 + LGL since leukemic cells had a morphology of typical lymphoblasts and of the cells could be stained with the neutralizing mik␤3 moAb.
not of LGL; in addition, the clinical presentation of the patient was that of an acute leukemia without any symptomatology of rheumatoid arthritis, chronic neutropenia or pure red blood cell aplasia, which are very frequent in cases of CD3 (20-2000 pM) of exogenous rIL-2 but no IL-2-induced cell proliferation could be observed (a stimulation index ranged CD3 − , CD16 − , CD57 +9 phenotype; in these cases, blast morphology was FAB L2 but not LGL. Moreover, there is a distinct between 0.22 and 0.4; not shown). Subsequently, NOI-90 cell proliferation was tested in the presence of antibodies against group of non-Hodgkin's lymphomas bearing CD16 + or/and CD56 + neoplastic cells which are diffuse large lymphomas the CD25, CD122 and IL-2. Table 4 indicates that IOT14␣, TU-27 and anti-IL-2 moAbs could significantly inhibit the in infiltrating (in 76% of the cases) the nasopharynx. 11 The relationship of all these clonal proliferations to T or NK cell vitro proliferation of NOI-90 cells. In all cases, this inhibition was dose dependent (not shown). Conversely, an irrelevant origin is difficult to establish. Based on the above observations the definition of the cell anti-HLA-DR moAb, used as control, could not significantly modify the proliferation of NOI-90 cells (Table 4) . In order to origin of NOI-90 cells is difficult. Although cells lack LGL morphology, the expression of CD3, CD56 and CD57 molanalyze the specificity of this antibody-dependent inhibition, the effect of other moAbs against the CD25 (7G7/B6) and ecules in association with the absence of CD16 expression and J H , TCR␤ and TCR␥ genes rearrangement, favor the CD122 (mik␤1 and mik␤3) on cell proliferation was tested. Both 7G7/B6 and mik␤1, which are not neutralizing, exhibhypothesis that NOI-90 cells are of non-T, non-B cell origin; however, their phenotype and genotype is compatible with ited a 20% and 25% inhibition, respectively, whereas mik␤3, which is neutralizing, demonstrated a 65% inhibition of cell that of NK cells but NOI-90 cells failed to demonstrate any specific NK activity. This lack of NK or LAK activity makes it proliferation (Table 4) (20) their own growth factor(s). We have previously shown that mik␤1 23500 ± 4520 (25) leukemic cells from patients with T cell acute lymphoblastic 2R and produce IL-2 suggesting that the IL-2/IL2R system may interesting material for further investigating its functional characteristics and defining molecular mechanisms which be involved in the proliferation of some T-ALL cells. 48 The investigation of the proliferation mechanisms of NOIregulate its differentiation and function. 90 cells demonstrates that leukemic cells possibly display an autocrine mechanism of proliferation involving the IL-2/IL2R system as in some T-ALL cells. Indeed, NOI-90 leukemic cells Acknowledgements express a low number of high affinity IL-2R which is practically unchanged during the whole culture period. The small We wish to thank Ms Youli Koraou and Popi Fetokaki for the differences of the K d among the different experiments probexcellent secretarial help with the preparation of the manuably represent the variability of the method and reagents used script. This work was supported in part by the Hellenic during the experimental period rather than specific modifiAnticancer Society, the Research Committee of the University cations of the receptor affinity. Despite the expression of high of Crete, the Cretan Association of Biomedical Research affinity IL-2R on NOI-90 cells, which theoretically are com-(PEVE) and the SPA program for Crete of the European Union. posed of both CD25 and CD122 chains, staining of the cells with the IOT14 and TU-27 moAbs revealed only 2% and 4% positive cells, respectively. However, using a panel of moAbs References against these molecules, it was observed that NOI-90 cells 
